Today's story
AstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook
AstraZeneca beat second-quarter profit expectations and reaffirmed its 2026 outlook despite concerns about future growth after a trial setback, as investors await further details on its earnings trajectory. Analysts are mixed but broadly positive, with several buy ratings and a focus on the upcoming Q2 results and oncology-driven revenue, amid a broader market backdrop of cautious trading ahead of earnings.
Business · 43 sources · Jul 27, 2026Read itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Pascal Soriot
Sir Pascal Claude Roland Soriot is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.
Everything about Pascal Soriot →- Occupation
- entrepreneur, veterinarian
- Position held
- chief executive officer
- Citizenship
- France
- Born
- May 23, 1959